Objective: Cancer-IgG is a newly-discovered molecule, mainly derived from epithelial carcinoma cells and is significantly correlated with differentiation, metastasis, local invasion, and poor prognosis of many cancers. In our previous study we detected IgG expression in oral epithelial carcinoma, including salivary adenoid cystic carcinoma (SACC), using an IgG-specific commercial antibody. Here, we explored the correlation between cancer-IgG and clinicopathological features of SACC.
Design: A total of 68 human SACC tissue specimens and 2 siRNAs were used to analyze the correlation between cancer-IgG and extra domain A (EDA)-containing fibronectin using the cancer-IgG-specific monoclonal antibody, RP215.
Results: We found an unexpected correlation between cancer-IgG and EDA fibronectin, both of which showed aberrant expression in SACC tissue samples. Both were highly expressed in SACC with nerve invasion. In our previous study, EDA fibronectin overexpression in SACC cells decreased N-cadherin expression. In the present study, we used SACC-83 cells, wherein EDA fibronectin is overexpressed and cancer-IgG is knocked down. EDA fibronectin expression was reduced with cancer-IgG knockdown, while cancer-IgG expression did not affect EDA fibronectin overexpression. Furthermore, knockdown of non-B cell-derived IgG in SACC cells decreased cellular motility (P<0.05) as well as increased E-cadherin and alpha-smooth muscle actin levels.
Conclusion: The results suggest that cancer IgG potentially regulates EDA fibronectin expression, thereby suggesting possible new therapeutic approaches for SACC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.archoralbio.2017.04.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Changes in various forms of fibronectin in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass - a prospective, observational study.
Sci Rep
December 2024
Clinical Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Borowska 213, 50-556, Wroclaw, Poland.
Coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) is associated with the transient activation of a systemic inflammatory response. Fibronectin (FN), an endogenous inflammatory mediator, is a key component of the extracellular matrix. This study aimed to detect changes in cellular and plasma FN levels, as well as its potential fragmentation or FN-fibrin complex formation, in 40 patients undergoing CABG with CPB.
View Article and Find Full Text PDFEDA Fibronectin Microarchitecture and YAP Translocation During Wound Closure.
bioRxiv
September 2024
Department of Bioengineering, Temple University, Pennsylvania.
Fibronectin (Fn) is an extracellular matrix glycoprotein with mechanosensitive structure-function. EDA Fn, a Fn isoform, is not present in adult tissue but is required for tissue repair. Curiously, EDA Fn is linked to both regenerative and fibrotic tissue repair.
View Article and Find Full Text PDFDAMPs Drive Fibroinflammatory Changes in the Glaucomatous ONH.
Invest Ophthalmol Vis Sci
October 2024
University of Wisconsin-Madison, Madison, Wisconsin, United States.
Article Synopsis
- - The study investigates the early molecular mechanisms behind glaucoma, focusing on B6.EDA+/+ mice, which express a damage-associated molecule (FN+EDA) that triggers an inflammatory response in the optic nerve head.
- - Researchers found that these mice experience significantly higher intraocular pressure and retinal damage compared to control mice, with increased expression of proteins like FN+EDA and biglycan linked to these changes.
- - Gene analysis and protein expression studies over two years revealed new molecular pathways related to glaucomatous damage, highlighting the role of FN+EDA in promoting inflammation in the optic nerve head as the mice aged.
Cancer-associated fibroblasts derived fibronectin extra domain A promotes sorafenib resistance in hepatocellular carcinoma cells by activating SHMT1.
Genes Dis
November 2024
Department of Oncology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
Article Synopsis
- Resistance to sorafenib treatment for advanced hepatocellular carcinoma (HCC) negatively impacts patient outcomes, and the role of the extracellular matrix in this resistance is not well understood.
- Research identified FN-EDA from cancer-associated fibroblasts as a key factor in this resistance, as it enhances SHMT1 enzyme levels in HCC cells through the TLR4/NF-κB signaling pathway, helping cells cope with the oxidative stress from sorafenib.
- Clinical validation showed that targeting the FN-EDA/SHMT1 pathway could potentially improve how well patients respond to sorafenib, indicating a new therapeutic strategy for HCC.
Modeling the profibrotic microenvironment in vitro: Model validation.
Biochem Biophys Res Commun
November 2024
Center for Regenerative Medicine, Medical Research and Education Institute, Lomonosov Moscow State University, 119192, Moscow, Russia.
Establishing the molecular and cellular mechanisms of fibrosis requires the development of validated and reproducible models. The complexity of in vivo models challenges the monitoring of an individual cell fate, in some cases making it impossible. However, the set of factors affecting cells in vitro culture systems differ significantly from in vivo conditions, insufficiently reproducing living systems.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!